Why the Pro Medicus Limited (ASX:PME) share price is rocketing higher today

The Pro Medicus Limited (ASX:PME) share price has rocketed higher in morning trade after announcing a major deal with Partners Healthcare in the United States…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The market may be sinking lower again today but the same cannot be said for the Pro Medicus Limited (ASX: PME) share price.

In morning trade the health imaging company's shares have rocketed over 10% higher to $10.11 following the announcement of a major new deal.

What was announced?

This morning Pro Medicus announced that its wholly-owned U.S. subsidiary, Visage Imaging, has signed a A$27 million, 7-year contract with Partners Healthcare.

Partners Healthcare is the largest health system in the state of Massachusetts and one of the largest and most respected health providers in North America.

According to the release, the contract is based on a transaction licensing model and will see Pro Medicus' Visage 7 technology implemented at Partners' two flagship hospitals, Massachusetts General Hospital and Brigham and Women's Hospital, eliminating their legacy PACS. It also includes scope to expand to other Partners network hospitals at a later date.

Pro Medicus CEO, Dr Sam Hupert, believes the deal is a milestone for Pro Medicus and that it is a testament to the quality of its technology.

He said: "Not only is it our biggest deal to date, there is the potential for further upside within the Partners network after this initial rollout is completed."

Before adding that these hospitals are: "two of the most prestigious medical institutions in North America renowned for their medical research, as well as their key roles as teaching hospitals for Harvard Medical School. The fact that both institutions selected Visage 7 as their platform of choice reinforces our view that Visage's leading edge technology is suitable for a broad range of clinical environments, including the most sophisticated and demanding users."

Should you invest?

While Pro Medicus' shares are certainly expensive, I believe deals like this demonstrate the enormous potential that the company has and why it could prove to be a great long-term buy and hold investment along with fellow healthcare technology companies Nanosonics Ltd (ASX: NAN) and Volpara Health Technologies Ltd (ASX: VHT).

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. recommends Pro Medicus Ltd. The Motley Fool Australia owns shares of and has recommended Nanosonics Limited, Pro Medicus Ltd., and VOLPARA FPO NZ. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why Boss Energy, Core Lithium, Latin Resources, and Santos shares are rising today

These ASX shares are having a good finish to the week. But why?

Read more »

Happy woman in purple clothes looking at asx share price on mobile phone
Share Gainers

Why Invictus Energy, Perpetual, Polynovo, and Zip shares are charging higher

These ASX shares are catching the eye on Thursday. What's going on?

Read more »

two men in mining hats shake hands on a deal with gas pipelines in the background, indicating a deal between Senex and 29 Metals
Share Gainers

Guess which ASX All Ords share just leapt 59% on a new gas discovery

Investors are bidding up the ASX All Ords energy share following a significant gas discovery in southern Africa.

Read more »

Businesswoman whispering in male colleague's ear as he looks surprised
Share Gainers

Up 118%: Is this 'high quality' stock the best-kept secret on the ASX 200?

Why are these pharmaceutical shares turning heads at the moment? The Elvest team explains.

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Share Gainers

Why Chalice Mining, Core Lithium, Perpetual, and Polynovo shares are racing higher

These ASX shares are having a very strong session on Wednesday. But why?

Read more »

A young boy points and smiles as he eats fried chicken.
Share Gainers

'Double-digit earnings growth': 2 fast-rising ASX shares not too late to buy

Get on these stocks before all their potential is realised, say Celeste analysts. So what are you waiting for?!

Read more »

Top 10 blank list on chalkboard
Share Gainers

Here are the top 10 ASX 200 shares today

It was back to reality for ASX shares today...

Read more »

Beautiful young couple enjoying in shopping, symbolising passive income.
Share Gainers

Why Droneshield, Origin, ResMed, and Whispir shares are pushing higher

These ASX shares are having a good time despite the market weakness.

Read more »